ATMS

Artemis Therapeutics Inc. [ATMS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ATMS Stock Summary

In the News

ATMS Financial details

Company Rating
-
Market Cap
55.79M
Income
-737K
Revenue
671K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
21 Aug 2023
P/E
-40.51
Forward P/E
-
PEG
-0.33
P/S
119.14
P/B
-47.93
P/C
-
P/FCF
-108.76
Quick Ratio
0.12
Current Ratio
0.15
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
3.73%
Revenue Q/Q
-14.56%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-473%
ROE
177%
ROC
1.61%
Gross Margin
83%
Oper. Margin
-304%
Profit Margin
-294%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.1121-4.5
52W High
-
52W Low
-
RSI
-
Rel Volume
0.71
Avg Volume
1.53K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0.7%, 0.7%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
VTSAX
NVDA
APC.DE
FXAIX
MIX.JO
Same Sector
EYLD
INPSX
CSBBANK.NS
NADA.DE
ELVT
Check Those
PFGC
EQFN
CCASX
600588.SS
RSKD
Similar Market Cap
CIL
FLUX
BWNG.L
ACVF
GFOR

Company Profile

Financial Services Shell Companies

Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.